UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis

The New England journal of medicine, 2019-12, Vol.381 (25), p.2429-2439

2019

Volltextzugriff (PDF)

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

The Journal of infectious diseases, 2023-03, Vol.227 (6), p.761-772

2023

Volltextzugriff (PDF)

Toll-like receptors' two-edged sword: when immunity meets apoptosis

European journal of immunology, 2007-12, Vol.37 (12), p.3311-3318

2007

Volltextzugriff (PDF)

Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy?

Clinical cancer research, 2007-08, Vol.13 (15), p.4565-4574

2007

Volltextzugriff (PDF)

TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells

Journal of Immunology, 2006-04, Vol.176 (8), p.4894-4901

2006

Volltextzugriff (PDF)

Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4 + T cell immunity within the FLUCOP consortium

Frontiers in immunology, 2022-10, Vol.13, p.982887-982887

2022

Volltextzugriff (PDF)

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

Frontiers in immunology, 2023-10, Vol.14, p.1260146-1260146

2023

Volltextzugriff (PDF)

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview

Human vaccines & immunotherapeutics, 2021-11, Vol.17 (11), p.4132-4143

2021

Volltextzugriff (PDF)

TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer

Cancer research (Chicago, Ill.), 2011-03, Vol.71 (5), p.1607-1614

2011

Volltextzugriff (PDF)

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

npj vaccines, 2019-12, Vol.4 (1), p.51-51, Article 51

2019

Volltextzugriff (PDF)

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets

Journal of translational medicine, 2011-04, Vol.9 (1), p.44-44, Article 44

2011

Volltextzugriff (PDF)

SAT-196 - Cell-mediated immunity analysis to assess the characteristics of immune response to bepirovirsen: Examples from the B-Clear study

Journal of hepatology, 2023-06, Vol.78, p.S1167-S1169

2023

Volltextzugriff (PDF)

Cell-mediated immunity analysis to assess the characteristics of immune response to bepirovirsen: Examples from the B-Clear study

Journal of hepatology, 2023-06, Vol.78, p.S1167-S1169

2023

Volltextzugriff (PDF)

CD208/Dendritic Cell-Lysosomal Associated Membrane Protein Is a Marker of Normal and Transformed Type II Pneumocytes

The American journal of pathology, 2004-03, Vol.164 (3), p.861-871

2004

Volltextzugriff (PDF)

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

The Journal of infectious diseases, 2018-05, Vol.217 (11), p.1750-1760

2018

Volltextzugriff (PDF)

Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay

Vaccine, 2020-02, Vol.38 (8), p.1953-1961

2020

Volltextzugriff (PDF)

IκB Kinase β Phosphorylates Dok1 Serines in Response to TNF, IL-1, or γ Radiation

Proceedings of the National Academy of Sciences - PNAS, 2004-12, Vol.101 (50), p.17416-17421

2004

Volltextzugriff (PDF)

Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination

The Journal of infectious diseases, 2021-12, Vol.224 (12), p.2025-2034

2021

Volltextzugriff (PDF)

Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study

The Journal of infectious diseases, 2024-02, Vol.229 (2), p.355-366

2024

Volltextzugriff (PDF)

MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer

Immunity (Cambridge, Mass.), 2013-04, Vol.38 (4), p.742-753

2013

Volltextzugriff (PDF)

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

The Journal of infectious diseases, 2021-10, Vol.224 (7), p.1139-1146

2021

Volltextzugriff (PDF)

Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols

Journal of immunological methods, 2023-12, Vol.523, p.113584-113584, Article 113584

2023

Volltextzugriff (PDF)

Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial

The Journal of infectious diseases, 2024-07, Vol.230 (1), p.e102-e110

2024

Volltextzugriff (PDF)

Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults

Journal of viral hepatitis, 2019-09, Vol.26 (9), p.1066-1075

2019

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

Toll-like receptors' two-edged sword: when immunity meets apoptosis

Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy?

TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells

Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4 + T cell immunity within the FLUCOP consortium

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview

TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets

SAT-196 - Cell-mediated immunity analysis to assess the characteristics of immune response to bepirovirsen: Examples from the B-Clear study

Cell-mediated immunity analysis to assess the characteristics of immune response to bepirovirsen: Examples from the B-Clear study

CD208/Dendritic Cell-Lysosomal Associated Membrane Protein Is a Marker of Normal and Transformed Type II Pneumocytes

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay

IκB Kinase β Phosphorylates Dok1 Serines in Response to TNF, IL-1, or γ Radiation

Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination

Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study

MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols

Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial

Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults

Suchergebnisse filtern